Pancreatitis News and Research

RSS
Pancreatitis is inflammation of the pancreas. The pancreas is a large gland behind the stomach and close to the duodenum—the first part of the small intestine. The pancreas secretes digestive juices, or enzymes, into the duodenum through a tube called the pancreatic duct. Pancreatic enzymes join with bile—a liquid produced in the liver and stored in the gallbladder—to digest food. The pancreas also releases the hormones insulin and glucagon into the bloodstream. These hormones help the body regulate the glucose it takes from food for energy.

Normally, digestive enzymes secreted by the pancreas do not become active until they reach the small intestine. But when the pancreas is inflamed, the enzymes inside it attack and damage the tissues that produce them.

Pancreatitis can be acute or chronic. Either form is serious and can lead to complications. In severe cases, bleeding, infection, and permanent tissue damage may occur.
New prediction model improves early detection of infected pancreatic necrosis

New prediction model improves early detection of infected pancreatic necrosis

GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events

GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events

Intravenous infusion of exenatide fails to reduce risks of complications in heart surgery patients

Intravenous infusion of exenatide fails to reduce risks of complications in heart surgery patients

New clinical trial offers hope for patients with rare immune disease IgG4-RD

New clinical trial offers hope for patients with rare immune disease IgG4-RD

Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes

Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes

Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease

Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease

Progress in early detection and screening methods for pancreatic cancer

Progress in early detection and screening methods for pancreatic cancer

Survey reveals lack of awareness about pancreatic cancer risk among adults under age 50

Survey reveals lack of awareness about pancreatic cancer risk among adults under age 50

Ozempic effective for patients with chronic kidney damage

Ozempic effective for patients with chronic kidney damage

GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

Renowned pancreatic surgeon Dr. Katherine A. Morgan joins NYU Langone

Renowned pancreatic surgeon Dr. Katherine A. Morgan joins NYU Langone

New approach to B-ALL treatment reduces side effects and enhances survival

New approach to B-ALL treatment reduces side effects and enhances survival

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Insulin resistance linked to 31 diseases and higher early death risk in women

Insulin resistance linked to 31 diseases and higher early death risk in women

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

AI analysis of Reddit reveals public interest in GLP-1 drugs for weight loss and mental health benefits

AI analysis of Reddit reveals public interest in GLP-1 drugs for weight loss and mental health benefits

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

New drug tirzepatide significantly improves sleep apnea and weight loss

New drug tirzepatide significantly improves sleep apnea and weight loss

New antioxidant biomaterial may provide relief to people living with chronic pancreatitis

New antioxidant biomaterial may provide relief to people living with chronic pancreatitis

Insurance denials hinder GLP1Ra use in children and teens with type 2 diabetes

Insurance denials hinder GLP1Ra use in children and teens with type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.